SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company, advancing a new class of immunotherapies leveraging the native human immune response, announced today it has been awarded a contract from the U.S. Department of Defense (DoD) to develop and test a Rapid Response Antibody... Read the full story
BWX Technologies, Inc. (NYSE: BWXT) announced today that a team led by subsidiary BWXT Advanced Technologies has been awarded a $14 million contract from the Office of the Secretary of Defense, Strategic Capabilities Office (SCO) for a mobile nuclear reactor design project.
SCO is partnering... Read the full story
The Defence Secretary has laid a written ministerial statement in Parliament, reproduced below.
In 2007 the government, endorsed by a Parliamentary vote, began a programme to maintain the UK’s nuclear deterrent beyond the early 2030s. The 2015 Strategic Defence and Security Review (Cm 9161)... Read the full story